FDA and Immunology Experts Call for Flexible Trial Design for Pandemic Vaccines

FDA and Immunology Experts Call for Flexible Trial Design for Pandemic Vaccines

Source: 
BioSpace
snippet: 

Traditional vaccine development and regulatory policies are changing in response to the current pandemic. Some of those approaches may become more common, expanding into other, non-pandemic-related areas in the future, according to experts speaking at a briefing hosted by The Commonwealth Fund and the Alliance for Health Policy on April 17.